Mr Lee C Webber

Faculty of Medicine, Department of Surgery & Cancer

Deputy Cancer Clinical Trials Operations Manager

Contact

Location

Radiotherapy BuildingHammersmith Campus

Summary

I am based at the Cancer Research UK Imperial Centre: Clinical Trials Section. I have 13 years experience working in cancer trials, primarily gynaecological malignancies. Since September 2019 I have been overseeing studies in ovary, breast and cancer of unknown primary, as well as working on pre- and post-funded studies approved by our trials oversight committee. Our team forms part of the Imperial Clinical Trials Unit (ICTU).

Publications

Journals

Ingemarsdotter CK, Tookman LA, Browne A, et al.Ingemarsdotter CK, Tookman LA, Browne A, Pirlo K, Cutts R, Chelela C, Khurrum KF, Leung EYL, Dowson S, Webber L, Khan I, Ennis D, Syed N, Crook TR, Brenton JD, Lockley M, McNeish IA close, 2015, Paclitaxel resistance increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control, Molecular Oncology, Vol:9, ISSN:1574-7891, Pages:791-805

McNeish IA, Ledermann JA, Webber L, et al.McNeish IA, Ledermann JA, Webber L, James L, Kaye SB, Hall M, Hall G, Clamp A, Earl H, Banerjee S, Kristeleit R, Raja F, Feeney A, Lawrence C, Dawson-Athey L, Persic M, Khan I close, 2014, A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, Annals of Oncology, Vol:25, ISSN:0923-7534, Pages:1988-1995

More Publications